BIOMARIN PHARMACEUTICAL INC Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.00 | 8,000 | 640,000 | 46,740 | 54.7 K to 46.7 K (-14.61 %) |
| Feb 24 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Option Exercise | M | 21.51 | 20,000 | 430,200 | 17,536 | |
| Feb 24 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Sell | S | 80.00 | 20,000 | 1,600,000 | 60,656 | 80.7 K to 60.7 K (-24.80 %) |
| Feb 24 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Buy | M | 21.51 | 20,000 | 430,200 | 80,656 | 60.7 K to 80.7 K (+32.97 %) |
| Feb 19 2014 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 31,500 | 0 | 73,850 | 42.4 K to 73.9 K (+74.38 %) |
| Feb 19 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 78,750 | 0 | 194,520 | 115.8 K to 194.5 K (+68.02 %) |
| Feb 19 2014 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Grant | A | 0.00 | 10,500 | 0 | 60,656 | 50.2 K to 60.7 K (+20.93 %) |
| Feb 19 2014 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 0.00 | 26,250 | 0 | 64,273 | 38 K to 64.3 K (+69.04 %) |
| Feb 19 2014 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 0.00 | 26,250 | 0 | 86,600 | 60.4 K to 86.6 K (+43.50 %) |
| Feb 19 2014 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 2,675 | 0 | 13,722 | 11 K to 13.7 K (+24.21 %) |
| Feb 19 2014 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 2,675 | 0 | 60,350 | 63 K to 60.4 K (-4.24 %) |
| Feb 04 2014 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | M | 21.51 | 10,000 | 215,100 | 64,155 | |
| Feb 04 2014 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 67.70 | 10,000 | 676,966 | 42,350 | 52.4 K to 42.4 K (-19.10 %) |
| Feb 04 2014 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Buy | M | 21.51 | 10,000 | 215,100 | 52,350 | 42.4 K to 52.4 K (+23.61 %) |
| Feb 07 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 4,000 | 51,960 | 86,500 | |
| Feb 07 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 4,000 | 51,960 | 54,740 | 50.7 K to 54.7 K (+7.88 %) |
| Feb 19 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Grant | A | 0.00 | 10,500 | 0 | 25,380 | 14.9 K to 25.4 K (+70.56 %) |